What is the fair value of Humana Inc (NYSE-HUM) stock?

The current fair value estimate for Humana Inc (NYSE-HUM) is $454.78. This implies an estimated upside of 7.8% versus the current market price.

Is Humana Inc (NYSE-HUM) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 7.8% versus the current market price.

What is the analyst price target for NYSE-HUM stock?

The available analyst price target for Humana Inc (NYSE-HUM) is $465.13. The analyst target implies estimated upside of 10.2%.

How is the financial health of Humana Inc?

The current financial health read for Humana Inc (NYSE-HUM) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Humana Inc's next earnings date?

The next earnings date currently listed for Humana Inc (NYSE-HUM) is November 6, 2026.

Does Humana Inc (NYSE-HUM) pay dividends?

Based on the current data, dividend yield is 0.8%, payment date is November 27, 2026.

What is the P/E ratio for Humana Inc (NYSE-HUM)?

The current P/E ratio listed for Humana Inc (NYSE-HUM) is 39.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Humana Inc?

The current market capitalization listed for Humana Inc is 50.682 B.

What is the enterprise value of Humana Inc?

The current enterprise value listed for Humana Inc is 57.303 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Humana Inc?

The ticker symbol for Humana Inc is NYSE-HUM, and the stock is listed on NYSE.

Where is Humana Inc (NYSE-HUM) listed?

Humana Inc (NYSE-HUM) is listed on NYSE.

What is the debt-to-total-capital ratio for Humana Inc?

The current debt-to-total-capital ratio listed for Humana Inc is 22.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Humana Inc?

The free float listed for Humana Inc is 99.8%. Free float helps investors understand how much of the share base is available for public trading.

Humana Inc (HUM) Fair Value & Stock Analysis

Humana Inc (HUM)

Humana Inc. is a U.S.-based healthcare company listed on the NYSE under the ticker HUM. As a common equity security, it represents ordinary shares in the company. Humana focuses on medical and specialty insurance products and operates through two segments: Insurance and CenterWell. Its Insurance business includes Medicare Advantage plans, stand-alone Medicare prescription drug plans, Medicare supplement coverage, and specialty products such as dental, vision, life, and disability insurance, along with administrative services for military health programs and pharmacy benefit management. The CenterWell segment provides senior-focused primary care, home health services, post-acute care coordination, pharmacy solutions, and hospice care. Founded in 1961 and headquartered in Louisville, Kentucky, the company adopted the Humana name in 1974.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Payment Date	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-HUM	$454.78	7.8% Upside	Fair	$465.13	10.2% Upside	Fair	Good	November 27, 2026	0.8%	November 6, 2026	39.6x	2.6x	0.3x	50.682 B	57.303 B	22.5%	99.8%	5.6	33.6%	152.4%